Slovenski konopljin socialni klub

Patent nad zdravili iz konoplje

Vsaj od leta 1974 je kristalno jasno da konoplja zdravi raka.
Oglejte si morje študij ki to potrjujejo.
In seveda patente na temo konoplje in kaj v njih piše.
In kdo si jih lasti.


These same chemicals can have a unique effect on each vital organ, homeostatically and holistically aiding them in their roles. This includes the kidneys and the nephrological system.
Many scientific studies have reported that various cannabinoids (both natural and synthetic) exert a wide range of growth-inhibiting effects on cancer cells, including:
- Triggering cell death, through a mechanism called apoptosis.
- Stopping cells from dividing.
- Preventing new blood vessels from growing into tumours –a process termed angiogenesis.
- Reducing the chances of cancer cells to metastasize through the body, by stopping cells from moving or invading neighbouring tissue.
- Speeding up the cell’s internal ‘waste disposal machine’ –a process known as autophagy – which can lead to cell death.

Please Share

All the US patents on cannabinoids that proves cannabis is a safe effective medicine.

US Patent 4837228
Cannabichromene (CBC)

US Patent 4189491
Glaucoma Treatment

US Patent 5631297
Anandamide Compounds

US Patent 6132762
Pain, inflammation and arthritis
Bolečine , vnetja in artritis

US Patent 6410588
Cannabidiol and inflammatory diseases
Kanabidiol in vnetne bolezni (CBD)

US Patent 6974568
Treatment for coughs

US Patent 6630507
Inflammatory and autoimmune diseases
Strokes, Alzheimer’s and Parkinson’s
Vnetne in avtoimunske bolezni
Kapi, Alzheimerjeva in Parkinsonova

US Patent 7741365
Novel polycyclic cannabinoid analogs

US Patent 7597910
Prostate cancer and prostatitis
Rak prostate in prostatitis

US Patent 7977107
Detecting traces of cannabinoids
Odkrivanje sledov kanabinoidov

US Patent 8071641
Diabetes and insulitis
Diabetes in insulitis

US Patent 8242178
Cannabidiol and autoimmune hepatitis
Kanabidiol in avtoimunski hepatitis

US Patent 8034843
Nausea, vomiting and motion sickness
Slabost, bruhanje in potovalna bolezen

New Cannabis vs. Cancer Patent Sought…/new-can...patent-so…
All Languages listed-International Association for Cannabis as Medicine
English-International Association for Cannabis as Medicine…


Recenzirane strokovne študije glede marihuane in RAKA :

Cannabinoid receptor systems: therapeutic targets for tumour intervention. UK
Sistemi Kanabinoidnih receptorjev : terapevtski cilji za intervencijo tumorja.

High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells. UK
Visoke koncentracije kanabinoidov aktivirajo apoptozo človeških U373MG gliomom celic.

Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. UK
Agonisti receptorjev Kanabinoidov so mitohondrijski inhibitorji: enotna hipoteza o tem, kako kanabinoidi modulirajo delovanje mitohondrijev in povzročijo smrt celice.

The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. UK
Kanabinoid Delta (9 ) tetrahidrokanabinol zavira RAS-MAPK in PI3K-AKT preživetveno signalizacijo in inducira BAD-posredovano apoptozo pri rakavih celicah debelega črevesa.

Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. UK
S konopljo povzročena citotoksičnost v levkemičnih celičnih linijah: Vloga receptorjev kanabinoidnih in MAPK poti.

Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Delta9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells. USA
Ciljanje kanabinoidnih receptorjev za zdravljenje levkemije: vloga presluha med zunanjo in notranjo potjo v Delta9-tetrahidrokanabinola (THC) inducirani apoptozi celic Jurkat.

The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. USA
Stopnja izraza CB1 in CB2 receptorjev določi njihovo učinkovitost pri induciranju apoptoze v astrocitomih.

Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression. USA
Kanabidiol inducirano apoptozo v človeške celice levkemije: Vloga kanabiola pri urejanju P22PHOX in Nox4 izražanja.

Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. USA
Kanabidiol krepi zaviralne učinke delta9-tetrahidrokanabinola pri širjenju in preživetju človeških glioblastom celic.

Cannabinoids and the immune system. USA
Kanabinoidi in imunski sistem.

Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. USA
Delta(9)-tetrahidrokanabinol inducirano apoptozo v timus in vranico kot mehanizem za imunosupresijo

Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. USA
Delta9-tetrahidrokanabinol inducirane apoptoze v Jurkat levkemičnih celicah T, ki je urejeno s prenosom Bad do mitohondrijev

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. USA
Kanabinoidno inducirana apoptoza v imunskih celicah, kot pot do imunosupresije.

Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. USA
(Sintetični Kanabinoidni receptor Agonisti)zavira rast tumorja in metastaz raka dojke.

Cannabinoids for cancer treatment: progress and promise. USA
Kanabinoidi za zdravljenje raka: napredek in obljube.

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. USA
Ciljanje CB2 kanabinoidnih receptorjev kot nova terapija za zdravljenje malignih limfoblastnih bolezni.

Cannabinoid receptor as a novel target for the treatment of prostate cancer. USA
Kanabinoidni receptor kot nov cilj za zdravljenje raka prostate.

In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas. USA
Učinki kanabinoidov na makromolekularni biosintezi na Lewis pljučnih karcinomih.

Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. USA
Kanabidiol kot zaviralec id-1 izraženih genov v agresivnih celicah raka dojke.

Cannabinoids as novel anti-inflammatory drugs. USA
Kanabinoidi kot nova protivnetna zdravila.

De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. SPAIN
Novo sintetizirani ceramid je vključen v kanabinoidnio-inducirane apoptoze.

Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis. SPAIN
Amphiregulin je dejavnik za odpornost gliom celic na kanabinoidno inducirane apoptoze .

Cannabinoids and cell fate. SPAIN
Kanabinoidi in usoda celic.

Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. SPAIN
Delta9-tetrahidrokanabinol inducira apoptozo v človeški PC-3 celici prostate preko mehanizma, ki je neodvisen od receptorjev.

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. SPAIN
Delta9-tetrahidrokanabinol inducira apoptozo v C6 celicah glioma.

Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. SPAIN
Kanabinoidi zavirajo vdor glioma celic

Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. SPAIN
Kanabinoidi ščitijo astrocite iz Ceramidno-inducirane apoptoze

Hypothesis: cannabinoid therapy for the treatment of gliomas? SPAIN
Hipoteza: kanabinoidna terapija za zdravljenje gliomov?

Involvement of cannabinoids in cellular proliferation. SPAIN
Vključenost kanabinoidov v celično proliferacijo.

Effects on cell viability. SPAIN
Vpliv na sposobnost preživetja celic.

Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. SPAIN
Kanabinoidno inducirana apoptoza pankreasnih tumorskih celic prek endoplazemskih retikulum genov povezanih s stresom.

Cannabinoids and gliomas. SPAIN
Kanabinoidi in gliomi.

Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. SPAIN
Delta9-tetrahidrokanabinol zavira potek celičnega ciklusa v človeških celicah raka dojke s pomočjo regulacije Cdc2.

Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas. SPAIN
Nasprotne spremembe izražanja v kanabinoidnih CB1 in CB2 receptorjih v človeških gliomih.

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. SPAIN
Zaviranje rasti tumorjev kože ... z aktivacijo kanabinoidnih receptorjev.

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2. SPAIN
Inhibicija rasti človeškega tumorja prostate PC - 3 celic s kanabinoidi R ( + ) - Methanandamide in JWH - 015 : vključevanje CB2 .

Control of the cell survival/death decision by cannabinoids. SPAIN

The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. SPAIN

The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. SPAIN

p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells. SPAIN

Cannabinoids and ceramide: two lipids acting hand-by-hand. SPAIN

Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development. SPAIN

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. SPAIN

Cannabinoid receptors as novel targets for the treatment of melanoma. SPAIN

JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. SPAIN

Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. SPAIN

Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis. SPAIN

Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity? SPAIN

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders. ITALY

Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines. ITALY

Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. ITALY

The endocannabinoid anandamide neither impairs in vitro T-cell function nor induces regulatory T-cell generation. ITALY

Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism. ITALY

The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro. ITALY

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. ITALY

Cannabinoids in intestinal inflammation and cancer. ITALY

The endocannabinoid system as a target for the development of new drugs for cancer therapy. ITALY

Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma. ITALY

Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review). ITALY

The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. ITALY

Cannabinoids as potential new therapy for the treatment of gliomas. ITALY

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. ITALY

Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. ITALY

Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells. ITALY

Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. ITALY

A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. ITALY

Endocannabinoids in the immune system and cancer. ITALY

R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway. GERMANY

Antitumorigenic effects of cannabinoids beyond apoptosis. GERMANY

Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells. GERMANY

Cannabinoid receptors in human astroglial tumors. GERMANY

Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. GERMANY

Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1. GERMANY

Pharmacokinetics and pharmacodynamics of cannabinoids. GERMANY

Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. ISRAEL

Cannabinoids and cancer. ISRAEL

Cannabinoids in health and disease. ISRAEL

A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells. ISRAEL

Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells. ISRAEL

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. ISRAEL

HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor. ISRAEL

Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans. SWITZERLAND

Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. SWITZERLAND

Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies? SWITZERLAND

Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. SWITZERLAND

Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation. SWEDEN

Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma. SWEDEN

Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. SWEDEN

Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism. SWEDEN

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. HUNGARY

Pharmacological synergism between cannabinoids and pa*censored*axel in gastric cancer cell lines. JAPAN

Different views on the association between cannabinoids and cancer. SLOVAKIA

Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells. KOREA

Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma. SAUDI ARABIA

Cannabinoids in the treatment of cancer. NEW ZEALAND

Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein. POLAND

Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers? UKRAINE

A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells. TAIWAN

The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration. THAILAND

Konoplja zdravi, zato zaupaj naravi

p.s: ker mi ni vseeno kaj bo jutri - zu3 se na fu3

Sorodne povezave


Trackback URL for this entry:

No trackback comments for this entry.
Patent nad zdravili iz konoplje | 1 komentarjev. | Nov uporabnik
Za komentarje so odgovorni njihovi avtorji. Spletna stran ni odgovorna za komentarje uporabnikov.
Patent nad zdravili iz konoplje
Prispeval/a: Admin dne petek, marec 21 2014 @ 02:04 CET


Urejeno petek, marec 21 2014 @ 02:06 CET od uporabnika Admin